Friday, October 28, 2005 7:03:54 PM
OK EPRIM, here's the rule (see below), the company has 71 days from August 1st to file the 8K financials on the asset purchase, which would be on or about the 10th day of October. No extension was applied for and none will be granted. Dog
NowAuto, Inc. Closes Its Definitive Asset Purchase Agreement with Global-E Investments
SCOTTSDALE, Ariz., Aug 01, 2005 /PRNewswire-FirstCall via COMTEX/ -- NowAuto,
From SEC
Update M&A checklists. Many of the new Form 8-K items may be
triggered by mergers and acquisitions. Entering into an acquisition or disposition agreement will trigger a Form 8-K disclosure requirement under Item 1.01 (definitive material agreements) if the agreement is “material.” Consummating the acquisition or disposition will trigger a second Form 8-K requirement under Item 2.01 (completion of acquisition or disposition of assets) if the acquisition or disposition is “significant.” It is possible that a company might deem an acquisition or disposition to be “material” under Item 1.01 but not “significant” under Item 2.01. Financial statements of the acquired entity, and any required pro forma financial statements covering the acquisition, will be required to be filed within 71 days of the date on which the Item 2.01 Form 8-K is due. An acquisition could also trigger a Form 8-K requirement under Item 2.03 (direct financial obligations) if the company borrows money to pay for the acquisition, or Item 3.02 (unregistered sales of equity securities) if equity
constituted a portion of the consideration for the acquisition.
NowAuto, Inc. Closes Its Definitive Asset Purchase Agreement with Global-E Investments
SCOTTSDALE, Ariz., Aug 01, 2005 /PRNewswire-FirstCall via COMTEX/ -- NowAuto,
From SEC
Update M&A checklists. Many of the new Form 8-K items may be
triggered by mergers and acquisitions. Entering into an acquisition or disposition agreement will trigger a Form 8-K disclosure requirement under Item 1.01 (definitive material agreements) if the agreement is “material.” Consummating the acquisition or disposition will trigger a second Form 8-K requirement under Item 2.01 (completion of acquisition or disposition of assets) if the acquisition or disposition is “significant.” It is possible that a company might deem an acquisition or disposition to be “material” under Item 1.01 but not “significant” under Item 2.01. Financial statements of the acquired entity, and any required pro forma financial statements covering the acquisition, will be required to be filed within 71 days of the date on which the Item 2.01 Form 8-K is due. An acquisition could also trigger a Form 8-K requirement under Item 2.03 (direct financial obligations) if the company borrows money to pay for the acquisition, or Item 3.02 (unregistered sales of equity securities) if equity
constituted a portion of the consideration for the acquisition.
Recent FITY News
- Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace • GlobeNewswire Inc. • 01/05/2026 06:08:59 PM
- Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace • InvestorsHub NewsWire • 01/05/2026 06:00:00 PM
- Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer • GlobeNewswire Inc. • 10/09/2025 02:23:35 PM
- Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer • InvestorsHub NewsWire • 10/09/2025 02:00:00 PM
- Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc. • GlobeNewswire Inc. • 09/30/2025 01:56:45 PM
- Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc. • InvestorsHub NewsWire • 09/30/2025 01:45:00 PM
- Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB • GlobeNewswire Inc. • 09/23/2025 01:07:25 PM
- Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB • InvestorsHub NewsWire • 09/23/2025 12:35:36 PM
- Fifty1 Labs, Inc. Leadership Publishes Landmark Framework to Unlock Global Oncology Data Through AI-Driven Real-World Evidence • InvestorsHub NewsWire • 09/04/2025 12:30:00 PM
- Fifty1 Labs Partners with LUNR Aerospace to Pioneer AI-Driven Drug Repurposing for Space Medicine, Strategic Collaboration Aims to Harness AI and Orbital Access to Revolutionize Astronaut Health Solutions in a $2 Billion Market by 2032 • InvestorsHub NewsWire • 08/26/2025 01:00:00 PM
- Fifty1 Labs, Inc. Subsidiary Fifty1 AI Labs Partners with ViRx@Stanford Under 'BE READI!' Initiative to Advance AI-Powered Antiviral Drug Repurposing • InvestorsHub NewsWire • 08/22/2025 02:30:00 PM
- Fifty1 Labs, Inc. and BioSpark AI Unlock 2,000+ Real-World Treatment Pathways to Accelerate Functional Medicine Innovation • InvestorsHub NewsWire • 08/12/2025 12:30:00 PM
- Fifty 1 Labs, Inc. Hosts Successful Virtual Shareholder Teleconference, Showcasing AI-Driven Functional Medicine Strategy and World-Class Leadership • InvestorsHub NewsWire • 07/29/2025 01:00:00 PM
- Fifty 1 Labs, Inc. to Host Virtual Shareholder Teleconference Featuring World-Class Leadership Team, including Dr. James Orbinski, who received the Nobel Peace Prize on Behalf of Médecins Sans Frontières • InvestorsHub NewsWire • 07/28/2025 12:30:00 PM
- Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies • InvestorsHub NewsWire • 07/17/2025 12:30:00 PM
- Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • InvestorsHub NewsWire • 07/10/2025 12:30:49 PM
- Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • InvestorsHub NewsWire • 07/08/2025 12:30:00 PM
- Fifty 1 Labs, Inc. Accelerates Growth with New CEO, BioSentry Division Launch and Shareholder Dividend; Company Pursues Strategic Growth Through UAV Partnership and Targeted Acquisitions in Advanced Tech and Wellness • InvestorsHub NewsWire • 04/30/2025 12:32:59 PM
- UAV Corp and Genetic Networks Announce Strategic Collaboration to Combat Biohazards with Cutting-Edge Technology, Genetic Networks Signs MOU with UMAV • InvestorsHub NewsWire • 04/09/2025 01:00:00 PM
